You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
|
|---|---|
| Published in |
Lancet Oncology, June 2023
|
| DOI | 10.1016/s1470-2045(23)00242-5 |
| Pubmed ID | |
| Authors |
James J Harding, Jia Fan, Do-Youn Oh, Hye Jin Choi, Jin Won Kim, Heung-Moon Chang, Lequn Bao, Hui-Chuan Sun, Teresa Macarulla, Feng Xie, Jean-Phillippe Metges, Jie'er Ying, John Bridgewater, Myung-Ah Lee, Mohamedtaki A Tejani, Emerson Y Chen, Dong Uk Kim, Harpreet Wasan, Michel Ducreux, Yuanyuan Bao, Lisa Boyken, Jiafang Ma, Phillip Garfin, Shubham Pant, HERIZON-BTC-01 study group, Ghassan Abou-Alfa, Jorge Adeva Alfonso, Massimo Aglietta, Ari Baron, Muhammad Beg, Paula Carrasco Aguirre, Eric Chen, Ying Cheng, Antonio Cubillo Gracián, Laetitia Dahan, Filippo De Braud, Elisabetta Fenocchio, Olumide Gbolohon, Roopinder Gillmore, Marine Jary, Milind Javle, Yixing Jiang, Jung Hun Kang, Gentry George King, Madappa Kundranda, Laura Layos, Daneng Li, Tingbo Liang, Sara Lonardi, Omkar Marathe, Sebastian Mondaca, Andrés J. Muñoz Martin, Joon Oh Park, Roberto Pazo Cid, Paula Ribera Fernandez, Lorenza Rimassa, Rosa Rodriguez Alonso, Saeed Sadeghi, Aaron Scott, Benjamin Tan, David Tougeron, Qiang Yan, Xiaoyu Yin, Haitao Zhao |
X Demographics
The data shown below were collected from the profiles of 110 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 34 | 31% |
| Spain | 7 | 6% |
| United Kingdom | 4 | 4% |
| France | 3 | 3% |
| Brazil | 3 | 3% |
| Germany | 2 | 2% |
| Mexico | 1 | <1% |
| Taiwan | 1 | <1% |
| Thailand | 1 | <1% |
| Other | 10 | 9% |
| Unknown | 44 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 50 | 45% |
| Practitioners (doctors, other healthcare professionals) | 28 | 25% |
| Scientists | 27 | 25% |
| Science communicators (journalists, bloggers, editors) | 5 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 27 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 19% |
| Other | 4 | 15% |
| Student > Doctoral Student | 1 | 4% |
| Librarian | 1 | 4% |
| Student > Ph. D. Student | 1 | 4% |
| Other | 3 | 11% |
| Unknown | 12 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 22% |
| Immunology and Microbiology | 3 | 11% |
| Engineering | 2 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
| Unknown | 15 | 56% |
Attention Score in Context
This research output has an Altmetric Attention Score of 677. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2024.
All research outputs
#31,705
of 25,738,558 outputs
Outputs from Lancet Oncology
#33
of 6,937 outputs
Outputs of similar age
#826
of 390,874 outputs
Outputs of similar age from Lancet Oncology
#3
of 104 outputs
Altmetric has tracked 25,738,558 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,937 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 390,874 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 104 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.